Mycobacterium avium brain abscess at the initiation of highly active antiretroviral therapy

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 23, Issue 2, 2004, Pages 142-144

  Berger, P ^a   Lepidi, H ^b   Drogoul Vey, M P ^c   Poizot Martin, I ^c   Drancourt, M ^a  

^a CNRS   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

^c HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; AZITHROMYCIN; BACTERIAL DNA; CD4 ANTIGEN; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; EFAVIRENZ; ENFUVIRTIDE; ETHAMBUTOL; FLUOROURACIL; FOSCARNET SODIUM; LAMIVUDINE; RIFABUTIN; STAVUDINE; TENOFOVIR; VIRUS RNA;

ADULT; ARTICLE; BACTERIUM ISOLATION; BRAIN ABSCESS; BRAIN BIOPSY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS; EPILEPTIC STATE; GLASGOW COMA SCALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LEUKOCYTE COUNT; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; PRIORITY JOURNAL; RETINITIS; TREATMENT FAILURE; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-BACTERIAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTITUBERCULAR AGENTS; BRAIN ABSCESS; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MYCOBACTERIUM AVIUM; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; RARE DISEASES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 1642322308     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-003-1070-8     Document Type: Article

References (9)

1. Uldry PA, Bogousslavsky J, Regli F, Chave JP, Beer V (1992) Chronic Mycobacterium avium complex infection of the central nervous system in a nonimmunosuppressed woman. Eur Neurol 32:285-288
2. Murray R, Mallal S, Heath C, French M (2001) Cerebral Mycobacterium avium infection in an HIV-infected patient following immune reconstitution and cessation of therapy for disseminated Mycobacterium avium complex infection. Eur J Clin Microbiol Infect Dis 20:199-201
3. Cinti SK, Kaul DR, Sax PE, Crane LR, Kazanjian PH (2000) Recurrence of Mycobacterium avium infection in patients receiving highly active antiretroviral therapy and antimycobacterial agents. Clin Infect Dis 30:511-514
4. Hassell M, French MA (2001) Mycobacterium avium infection and immune restoration disease after highly active antiretroviral therapy in a patient with HIV and normal CD4+ counts. Eur J Clin Microbiol Infect Dis 20:889-891
5. Price LM, O'Mahony C (2000) Focal adenitis developing after immune reconstitution with HAART. Int J STD AIDS 11:685-686
6. Aberg JA, Chin-Hong PV, McCutchan A, Koletar SL, Currier JS (2002) Localized osteomyelitis due to Mycobacterium avium complex in patients with human immunodeficiency virus receiving highly active antiretroviral therapy. Clin Infect Dis 35:E8-E13
7. Brown M, Williams IG, Miller RF (2001) Deterioration of disseminated cutaneous Mycobacterium avium complex infection with a leukaemoid reaction following institution of highly active antiretroviral therapy. Sex Transm Infect 77:149-150
8. DeSimone JA, Pomerantz RJ, Babinchak TJ (2000) Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 133:447-454
9. Peterson PK, Gekker G, Hu S, Sheng WS, Anderson WR, Ulevitch RJ, et al. (1995) CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect Immunol 63:1598-1602